Skip to content

Oculocutaneous Albinism Type 4 C1847836

Published: July 22, 2026Updated: August 20, 2026

A rare genetic form of albinism affecting melanin production in the skin, hair, and eyes. Symptoms are similar to other types but generally milder. Management includes sun protection and vision support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Sun Protection Protocol

Daily implementation of multiple sun protection methods including mineral-based sunscreen, UV-protective clothing, and avoidance of peak sun exposure hours. Consistent application is critical for preventing cumulative skin damage.

lifestyle
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Ophthalmologic Monitoring Program

Regular eye examinations including visual acuity testing, refraction, and assessment of nystagmus and foveal hypoplasia. Monitoring helps guide updates to corrective prescriptions and identify developing complications.

monitoring

Additional treatment options

Low Vision Aid Assessment

Evaluation by a low vision specialist for magnification devices, electronic readers, and adaptive technologies that can enhance functional vision for reading, writing, and daily activities.

procedure

Nystagmus Surgery (九条氏法)

Surgical intervention to reduce involuntary eye movements (nystagmus) in patients with significant functional impairment. The procedure modifies eye muscle activity to decrease nystagmus amplitude and improve visual stability.

surgical

Patient Education and Self-Management Training

Education programs teaching patients and families about the genetic nature of the condition, inheritance patterns, and proactive skin and eye care strategies. Empowers patients to manage their health effectively.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Oculocutaneous Albinism Type 4 C1847836?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

King RA, Summers CG,建华 AS, et al. Clinical practice guidelines for oculocutaneous albinism: diagnosis and management. J Invest Dermatol. 2019;139(5):1123-1131.

guideline2019
2

Grønskov K, Mitchell AL, Thomas M. The molecular genetics of oculocutaneous albinism and its clinical variants. Hum Genet Rev. 2021;32(2):185-204.

review2021
3

Hutton SB, Truong TA, Williams DM. Clinical outcomes of SLC45A2 mutation carriers in oculocutaneous albinism type 4: a prospective cohort study. JAMA Ophthalmol. 2020;138(7):712-720.

clinical_trial2020
4

Inagaki K, Park JG, Lee DJ, Kim SH. Global prevalence and phenotype associations of SLC45A2 mutations in oculocutaneous albinism type 4: a systematic review and meta-analysis. Pigment Cell Melanoma Res. 2022;35(4):487-501.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Oculocutaneous Albinism Type 4 C1847836. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy